Optogenetic tools for the dissection of oncogenic signaling mediated by kinases
用于解析激酶介导的致癌信号的光遗传学工具
基本信息
- 批准号:9891973
- 负责人:
- 金额:$ 18.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:6-Phosphofructo-2-kinaseAllosteric RegulationBiological ModelsBiological ProcessCancer BiologyCatalytic DomainCell CompartmentationCell CycleCell physiologyCellsClosure by clampCyclic AMP-Dependent Protein KinasesDevelopmentDissectionEngineeringEnsureEnzymesEventGlycolysisGuidelinesHomodimerizationHumanIndividualLightLight CellLightingLocationMaintenanceMalignant NeoplasmsMasksMediatingMetabolicMethodsMolecular ConformationOncogenicOrganPathologicPathway interactionsPharmacologyPhosphorylationPhosphotransferasesPhotoreceptorsPhysiologicalPhysiological ProcessesPlayPositioning AttributeProcessPropertyProtein EngineeringProtein KinaseProteinsReagentRegulationRoleScientistSignal PathwaySignal TransductionSignaling ProteinSiteSpecificityStructureSystemTestingTimeUp-RegulationWarburg Effectbasecancer cellcell motilitycell transformationdriving forcefructose-6-phosphategenetic manipulationglucose metabolisminhibitor/antagonistnovelnovel strategiesnovel therapeuticsoptogeneticsprotein metabolitespatiotemporalsrc-Family Kinasestooltumortumorigenesis
项目摘要
Aberrant signaling by protein kinases is one of the driving forces of tumorigenesis. Transition from
physiological to oncogenic processes is often triggered by changes in temporal and spatial regulation of
kinases. Dissection of these events is limited by the capabilities of current tools. It remains difficult to
manipulate activity of a specific kinase with precise timing and localization in living cells. To overcome current
limitations we propose to develop a novel broadly applicable optogenetic tool that will allow us to regulate
kinase activity in living cells using light. To control kinase activity in time and space we will engineer a novel
light-sensitive allosteric switch based on fungal photoreceptor Vivid that changes conformation upon
illumination with blue light. Insertion of the engineered switch at a specific site within the catalytic domain of a
kinase will allow us to achieve light-mediated regulation of the activity. This will enable tightly controlled,
reversible and localized regulation of a specific kinase in living cells. To demonstrate broad applicability of this
tool we will use it for regulation of oncogenic protein kinases Src, Abl and PKA. To further expand application
of this strategy we propose to develop light regulated PFKFB3, a structurally different kinase that
phosphorylates fructose 6-phosphate to promote glucose metabolism in cancer cells. The reagents used in this
method will be genetically encoded enabling ready application in many systems. Using light-mediated
regulation of tyrosine kinase Src we will determine its novel role in regulation of signaling pathways that
stimulate glucose metabolism during oncogenic transformation. We will employ light-controlled PFKFB3 to
identify its role in localized regulation of glycolysis in different subcellular compartments of the cell and its effect
on oncogenic morphodynamic changes and cell cycle.
蛋白激酶的异常信号传导是肿瘤发生的驱动力之一。过渡自
生理到致癌过程通常是由时间和空间调节的变化引发的
激酶。对这些事件的剖析受到当前工具功能的限制。仍然很难
在活细胞中通过精确的时间和定位来操纵特定激酶的活性。为克服电流
我们建议开发一种新颖的广泛适用的光遗传学工具,使我们能够调节
利用光在活细胞中激活激酶活性。为了在时间和空间上控制激酶活性,我们将设计一种新颖的
基于真菌光感受器 Vivid 的光敏变构开关,可改变构象
用蓝光照明。将工程开关插入到催化域内的特定位点
激酶将使我们能够实现光介导的活性调节。这将使严格控制,
活细胞中特定激酶的可逆和局部调节。为了证明这一点的广泛适用性
我们将使用它来调节致癌蛋白激酶 Src、Abl 和 PKA。进一步扩大应用
根据这一策略,我们建议开发光调节 PFKFB3,这是一种结构不同的激酶,
磷酸化果糖 6-磷酸,促进癌细胞中的葡萄糖代谢。本实验所用试剂
该方法将被基因编码,以便在许多系统中立即应用。使用光介导
酪氨酸激酶 Src 的调节我们将确定其在信号通路调节中的新作用
在致癌转化过程中刺激葡萄糖代谢。我们将采用光控PFKFB3来
确定其在细胞不同亚细胞区室糖酵解局部调节中的作用及其作用
致癌形态动力学变化和细胞周期。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREI V KARGINOV其他文献
ANDREI V KARGINOV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREI V KARGINOV', 18)}}的其他基金
Optogenetic Control of Tumor Initiation and Tumor Progression in vivo
体内肿瘤发生和进展的光遗传学控制
- 批准号:
10640927 - 财政年份:2022
- 资助金额:
$ 18.29万 - 项目类别:
Regulation of endothelial cell invasion, migration and cell junction plasticity
内皮细胞侵袭、迁移和细胞连接可塑性的调节
- 批准号:
10406685 - 财政年份:2022
- 资助金额:
$ 18.29万 - 项目类别:
Optogenetic Control of Tumor Initiation and Tumor Progression in vivo
体内肿瘤发生和进展的光遗传学控制
- 批准号:
10413468 - 财政年份:2022
- 资助金额:
$ 18.29万 - 项目类别:
Regulation of endothelial cell invasion, migration and cell junction plasticity
内皮细胞侵袭、迁移和细胞连接可塑性的调节
- 批准号:
10685981 - 财政年份:2022
- 资助金额:
$ 18.29万 - 项目类别:
Src-mediated pathways regulating adherens junction assembly.
Src 介导的途径调节粘附连接组装。
- 批准号:
10166863 - 财政年份:2017
- 资助金额:
$ 18.29万 - 项目类别:
Src-mediated pathways regulating adherens junction assembly.
Src 介导的途径调节粘附连接组装。
- 批准号:
9310733 - 财政年份:2017
- 资助金额:
$ 18.29万 - 项目类别:
New methods for activation of kinases and kinase circuits in living cells.
激活活细胞中激酶和激酶电路的新方法。
- 批准号:
8243734 - 财政年份:2012
- 资助金额:
$ 18.29万 - 项目类别:
相似国自然基金
基于钙敏感受体的不同激活状态进行多肽变构调节剂筛选以及结构导向的化学修饰改造
- 批准号:22307113
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
AMPA受体正向变构调节剂快速抗抑郁作用及其神经机制研究
- 批准号:82371524
- 批准年份:2023
- 资助金额:47 万元
- 项目类别:面上项目
GABAB受体复合体变构调节的生理和病理研究
- 批准号:32330049
- 批准年份:2023
- 资助金额:221 万元
- 项目类别:重点项目
P2X3靶向的无味觉失调的变构调节新策略及用于缓解原因未明难治性咳嗽的新分子发现
- 批准号:32371289
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于CaSR变构调节探讨大米蛋白肽-钙复合物改善肠上皮屏障功能的机制研究
- 批准号:32360576
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Discovery of allosteric activators of phospholipase C-gamma2 to treat Alzheimer's disease
发现用于治疗阿尔茨海默病的磷脂酶 C-gamma2 变构激活剂
- 批准号:
10901007 - 财政年份:2023
- 资助金额:
$ 18.29万 - 项目类别:
Defining the architecture and activation mechanisms of SynGAP
定义SynGAP的架构和激活机制
- 批准号:
10646985 - 财政年份:2023
- 资助金额:
$ 18.29万 - 项目类别:
Blunting of the Myofilament Beta-Adrenergic Response in HCM: Structural-Dynamic Mechanisms
HCM 中肌丝 β 肾上腺素反应的钝化:结构动力学机制
- 批准号:
10748921 - 财政年份:2023
- 资助金额:
$ 18.29万 - 项目类别:
Elucidating the SCP4 pathway as a multi-catalytic signaling dependency in acute myeloid leukemia
阐明 SCP4 通路作为急性髓系白血病的多催化信号传导依赖性
- 批准号:
10753227 - 财政年份:2023
- 资助金额:
$ 18.29万 - 项目类别: